IN2014CN04700A - - Google Patents

Info

Publication number
IN2014CN04700A
IN2014CN04700A IN4700CHN2014A IN2014CN04700A IN 2014CN04700 A IN2014CN04700 A IN 2014CN04700A IN 4700CHN2014 A IN4700CHN2014 A IN 4700CHN2014A IN 2014CN04700 A IN2014CN04700 A IN 2014CN04700A
Authority
IN
India
Prior art keywords
chromosome
mutations
ptx
copy
prn
Prior art date
Application number
Inventor
Chuenchit Boonchird
Wasin Buasri
Watanalai Panbangred
Jean Petre
Original Assignee
Bionet Asia Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49223105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014CN04700(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bionet Asia Co Ltd filed Critical Bionet Asia Co Ltd
Publication of IN2014CN04700A publication Critical patent/IN2014CN04700A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

BordetellaRecombinant pertussis strains derived from parent strain Tohama are provided. The new strains are obtained by homologous recombination using a allelic exchange vector pSS4245 which allows the replacement of sections of the bacterial chromosome without leaving any accessory mutations. The segment encoding PT subunit SI is replaced to introduce two mutations causing inactivation of the toxic activity of PT. This strain can be further modified to express increased amounts of rPT and/or PRN. A second copy of the ptx cluster of the five PT structural genes of the ptx ptl operon with their promoter and the ptl terminator and containing the above mutations can be inserted elsewhere on the chromosome. In addition a second copy of the PRN gene can be inserted on the chromosome. In both cases abandoned gene loci are selected as the insertion site to avoid the introduction of unwanted genetic alterations.
IN4700CHN2014 2011-12-21 2012-12-20 IN2014CN04700A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA201109417 2011-12-21
PCT/TH2012/000052 WO2013141823A1 (en) 2011-12-21 2012-12-20 Modified bordetella pertussis strains

Publications (1)

Publication Number Publication Date
IN2014CN04700A true IN2014CN04700A (en) 2015-09-18

Family

ID=49223105

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4700CHN2014 IN2014CN04700A (en) 2011-12-21 2012-12-20

Country Status (9)

Country Link
US (1) US9187754B2 (en)
EP (1) EP2802646B1 (en)
JP (1) JP5966018B2 (en)
KR (1) KR101696986B1 (en)
CN (1) CN104024400B (en)
BR (1) BR112014014950B1 (en)
ES (1) ES2642138T3 (en)
IN (1) IN2014CN04700A (en)
WO (1) WO2013141823A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017176807A2 (en) 2016-04-04 2017-10-12 University Of Virginia Patent Foundation Compositions for inhibiting formation of and/or disrupting bacterial biofilms and methods of use therefor
EP3820457A1 (en) 2018-07-09 2021-05-19 DBV Technologies Optimized epicutaneous vaccination
AU2019376832B2 (en) * 2018-11-06 2024-01-25 Glaxosmithkline Biologicals Sa Immunogenic compositions
WO2024061748A1 (en) * 2022-09-21 2024-03-28 Prokarium Limited Salmonella strain with chromosomally integrated landing pad

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358868A (en) 1987-11-24 1994-10-25 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
US5244657A (en) 1987-11-24 1993-09-14 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
US5221618A (en) 1987-11-24 1993-06-22 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
GB8727489D0 (en) 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
DK0396964T3 (en) * 1989-04-28 1995-10-30 Sclavo Spa Pertussis toxin mutants, Bordetella strains capable of producing such mutants, and their use in the development of antipertussis vaccines
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
GB9115332D0 (en) 1991-07-16 1991-08-28 Connaught Lab Manipulation of gene copy number in bordetella
WO1995009649A1 (en) * 1993-10-05 1995-04-13 Medeva Holdings B.V. Vaccine compositions
US20030072774A1 (en) * 1994-06-10 2003-04-17 Diane M. Gajewczyk Proteinaceous adjuvants
GB9923060D0 (en) * 1999-09-29 1999-12-01 Chiron Spa Vaccine
US20050026866A1 (en) * 2002-08-02 2005-02-03 Pawelek John M. Agents and methods for treatment of disease by oligosaccharide targeting agents
FI116068B (en) * 2003-09-15 2005-09-15 Fit Biotech Oyj Plc New selection system, useful vector, bacterial strains and cell selection method
WO2005090576A1 (en) * 2004-03-18 2005-09-29 Japan Health Sciences Foundation Dna construct for preventing pertussis infection
EP2432884B1 (en) 2009-05-22 2016-08-03 Merial, Inc. Antibiotic-free plasmid

Also Published As

Publication number Publication date
CN104024400A (en) 2014-09-03
US20140302558A1 (en) 2014-10-09
US9187754B2 (en) 2015-11-17
WO2013141823A1 (en) 2013-09-26
EP2802646B1 (en) 2017-05-10
KR20140107290A (en) 2014-09-04
JP2015502758A (en) 2015-01-29
CN104024400B (en) 2018-02-16
ES2642138T3 (en) 2017-11-15
KR101696986B1 (en) 2017-01-17
BR112014014950B1 (en) 2022-03-29
JP5966018B2 (en) 2016-08-10
EP2802646A1 (en) 2014-11-19
BR112014014950A2 (en) 2020-06-30
EP2802646A4 (en) 2015-08-12

Similar Documents

Publication Publication Date Title
BR112013033366A2 (en) toxin and antitoxin gene regulation for biological containment
MX2016009243A (en) Mutagenesis methods.
CY1117367T1 (en) ANTINEMATIC NUCLEAR ACID
IN2014CN04700A (en)
UA115023C2 (en) Polynucleotide molecules for gene regulation in plants
MX2014012364A (en) Compositions for controlling varroa mites in bees.
UA111193C2 (en) Use of n-(tetrazol-4-yl)- or n-(triazol-3-yl)arylcarboxamides or salts thereof for controlling unwanted plants in areas of transgenic crop plants being tolerant to hppd inhibitor herbicides
NZ627373A (en) Genes involved in noscapine production
TW201217533A (en) Genomics of actinoplanes utahensis
MY171760A (en) Microorganisms and methods for the production of caprolactone
EP4242330A3 (en) Generating northern leaf blight resistant maize
MY166780A (en) Genetic manipulation and expression system for pucciniomycotina and ustilaginomycotina subphyla
MX369867B (en) Gene and variations associated with bm1 phenotype, molecular markers, and their use.
PH12015501232A1 (en) Plant self nitrogen fixation by mimicking prokaryotic pathways
UA115235C2 (en) Bacillus thuringiensis toxin gene axmi335 and methods for its use
MX2013004044A (en) Bacterial ribonucleic acid cell wall compositions and methods of making and using them.
Han et al. Complete genome sequence of carotenoid-producing Microbacterium sp. strain PAMC28756 isolated from an Antarctic lichen
IN2014CN03414A (en)
WO2013030176A3 (en) Live attenuated influenza virus
IN2014DN10762A (en)
CO6761394A2 (en) Microorganisms resistant to reactive oxygen species
Ahn et al. Complete genome sequence of ionizing radiation-resistant Hymenobacter sp. strain PAMC26628 isolated from an Arctic lichen
Trombert et al. Reduced invasion to human epithelial cell lines of Salmonella enterica serovar Typhi carrying S. Typhimurium sopD2
CL2013003190A1 (en) Culture medium for human mesenchymal cells.
WO2012038837A3 (en) Methods for predicting response to anti-cancer therapy in cancer patients